Apteka Eskulap D.Niewiadomska-Śliwińska i Spółkasp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-06-02
Registered address
al. Konstytucji 3 Maja 18, 96-200 Rawa Mazowiecka, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 25 days late).

  • 202527/05/2026
  • 202422/05/2025
  • 202307/05/2024
  • 202209/06/2023
  • 202109/08/2022
  • 202027/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.66mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 147.71kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 1.51mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 279.06kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Eskulap D.Niewiadomska-Śliwińska i Spółka has been an NFZ healthcare provider since 2024. In 2024 it is performing 1 contract worth USD 4.51k.

Type of careNFZ branchContractsValue in 2024
Other services provided in pharmaciesłódzkie1USD 4.51k

Ownership

Owner
Marianna Zofia Niewiadomskaage 74
Dorota Renata Niewiadomska Śliwińskaage 51
Daniel Niewiadomskiage 46
Marian Niewiadomskiage 78

Manner of representation

Each partner is independently authorized to make declarations of will and sign on behalf of the company.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1999-08-28.

  • Bank spółdzielczy
    Bank spółdzielczy
    96 9302 1027 0000 0000 0000 0002

Debt

No entries in the National Debtors Register (KRZ).

Secured liabilities

Type
Assignment of receivables

Public aid

5 public aid cases recorded, with a total value of $8,126.

PurposeGross amount
Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies
$165
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,365
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,247

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Awicennasp. j.

Change history

DateEvent
2016-08-10PKD change
2014-01-16Name change
2010-01-28Switch to PKD 2007
2003-06-02Entered in the register

FAQ

Last updated: 2026-05-27